The efficacy of topical recombinant human epidermal growth factor gel in combination with fractional radiofrequency microneedle in the treatment of mild to moderate atrophic acne scar
Phase 3
Recruiting
- Conditions
- mild to moderate rolling and shallow boxcar acne scars
- Registration Number
- TCTR20201201003
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
1.mild to moderate rolling and shallow boxcar acne scars more than 6 months
Exclusion Criteria
1.Use isotretanoin or Vitamin A derivative drugs within 6 months
2.Have a laser treatment for acne scars within 6 months
3.History of topical anesthesia allergy
4.Patient using cardiac pacemaker or defibrillator
5.Patient that skin prone to keloid easily
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of acne scars after treatment with fractional radiofrequency and topical EGF in 3 months 3 months after treatment Investigator global assessment
- Secondary Outcome Measures
Name Time Method changing of volume of acne scar after treatment in 3 months 3 months after treatment Antera3D camera,Dermal density after treatment in 3 months 3 months after treatment DermaLab skin ultrasound,Patient satisfaction after treatment with fractional radiofrequency and topical EGF 3 months after treatment Questionairs